Q1 Productions
  • Events
    • Conferences
    • Forums
    • Webinars
  • Webinars
  • 2022 Event Calendar
  • Industries
    • Medical Device
    • Pharmaceutical
    • Life Science
    • Diagnostic
    • Healthcare
    • Food and Beverage
  • Sponsorship
  • Blog
  • About
    • About Us
    • Meet the Team
    • Mailing List
    • Attendee Stories
    • Career Opportunities
  • Contact
Select Page

Eli Lilly Reports Medication Slows Alzheimer’s Decline

According to an article via South Bend Tribune, “Eli Lilly & Co. reported Wednesday that an experimental medication might slow mild Alzheimer’s if people take it early enough, one of a handful of drugs in late-stage testing in the frustrating hunt for a better treatment.”  For more details, please visit: http://www.southbendtribune.com/life/health/alzheimer-s-drug-may-slow-decline/article_20395e61-48ef-5aca-9e00-936be0c5904a.html

Q1 Productions LLC
close

PRIA Healthcare is determined to accelerate the adoption and commercialization of innovative medical devices and procedures. PRIA’s patient access programs overcome investigational and experimental denials by leveraging data, patient rights, and expert case management. PRIA’s HIPAA-compliant CRM pairs a patient-based approach to case management and comprehensive reporting, providing clients with full transparency through PRIA’s patient access portal into the case-by-case adoption of their procedure categorized by payer, and ultimately building a foundational argument for establishing positive coverage policies.

PRIA’s patient access portal, combined with intuitive attention to detail and flexibility, enables PRIA to control the chaos of the environment and design effective, custom solutions for each client’s needs. PRIA’s passion comes from their commitment to give time and good health back to patients in need. Because of this, PRIA is continuously looking for ways to accelerate the adoption and commercialization of the most advanced medical procedures and treatments.

Visit Sponsor Website